Product fact sheet

MitoMAX 2.0: Technical Specifications & Independent Lab Data

Name: MitoMAX 2.0
Brand: Mito Red Light

MitoMAX 2.0 specifications with manufacturer hardware data and LightLab measurements for wall draw, radiant power and six-inch irradiance.

Red-light therapy guideReturn to the therapy guide and compare device specifications in context. Compare in context → Red-light panel comparisonOpen the comparison surface for this product family; missing comparable data is shown rather than guessed. Compare products →

Independent lab documentedFacts checked 2026-08-11

A 200-LED full-height Original 2.0 panel with current manufacturer specifications and manufacturer-hosted LightLab wall-draw, radiant-power and irradiance measurements.

Fit signals

larger two-wavelength panel comparisons with independent hardware data, buyers comparing measured wall draw with radiant power

Potential constraints

buyers looking for multi-wavelength spectral control, anyone converting lab output into a clinical ranking

Key tradeoff: The device has a useful independent hardware record, while its two-wavelength architecture is simpler than newer multi-band panels and does not by itself imply better or worse clinical performance.

This is a factual fit-and-tradeoff summary, not a product recommendation. Formula, device and brand claims remain manufacturer claims unless the cited source is explicitly regulatory or independent testing.

The MitoMAX 2.0 is a two-wavelength panel in Mito Red Light’s Original 2.0 family. The current manufacturer page lists 200 LEDs, 660 / 850 nm, 300 W published power consumption, a 60° beam angle and 36 × 9 × 3 in dimensions.

Independent LightLab measurements

Mito’s current independent-test index reproduces LightLab International results for a MitoMAX 2.0 sample tested on May 10, 2023. The report lists:

291.2 W measured wall draw;
113.4 W total radiant power;
55.7 mW/cm² average irradiance at six inches;
68.3 mW/cm² peak irradiance at six inches under the stated Area Below LEDs method.

The manufacturer’s 300 W power-consumption figure, the measured 291.2 W wall draw and the measured 113.4 W radiant power are different electrical and optical quantities. They should not be collapsed into one generic “power” number.

What the lab data can and cannot show

The LightLab figures describe hardware output from the tested sample under the report’s conditions. They do not establish a superior clinical outcome, an appropriate dose for a particular condition or better results than a lower-output device.

The publication has not repeated the LightLab protocol or performed same-protocol measurements of heat, fan noise or beam uniformity across competing panels.

For help interpreting irradiance, radiant power and electrical draw, see How to Read Red Light Device Specifications.

Technical specifications

Published specs and what they mean

Physical

Panel dimensions: 36 × 9 × 3 in
Weight: 20 lb

Optical

Published wavelengths: 660 / 850 nm (50/50)
LED count: 200 LEDs
Lens beam angle: 60°
Measured total radiant power: 113.4 W
Average irradiance at 6 in: 55.7 mW/cm²
Peak irradiance at 6 in: 68.3 mW/cm²

Electrical

Published power consumption: 300 W
Measured wall draw: 291.2 W

Controls

Timer range: 1–20 minutes

What the current record does not establish

Homeapotherapy has not independently repeated the LightLab test protocol.
The independent record is sample- and protocol-specific.
No product-level clinical superiority is established by these measurements.

A missing field is not evidence that the device lacks the feature or performs poorly. It means we do not currently have a sufficiently comparable, sourced value in the normalized record.

Source labels preserve provenance. Manufacturer specifications, ingredient lists and performance claims are not treated as independent clinical evidence; regulatory records and independent measurements are identified separately when available.

Dose and irradiance context

What the output number means over time

Fluence is a calculation, not a treatment recommendation. For continuous output, fluence in J/cm² equals irradiance in mW/cm² × seconds ÷ 1000. The calculation only remains meaningful at the measurement conditions used for the irradiance value.

Neutral conversion from the independent average measurement

Normalized measured average: 55.7 mW/cm².

Measurement conditions: Six inches; Area Below LEDs spatial averaging; 380–1000 nm context.

1 minute: 3.34 J/cm²
5 minutes: 16.71 J/cm²
10 minutes: 33.42 J/cm²
20 minutes: 66.84 J/cm²

These figures are arithmetic translations of one independently measured area-average irradiance. They are not suggested session lengths, target fluences or evidence that the same irradiance reaches tissue at a different distance, body contour, device mode or treatment geometry.

What this calculation still cannot tell you

whether this is an effective dose for any condition;
how irradiance changes at a different distance or across curved anatomy;
how much energy reaches tissue below the surface;
whether a study used the same wavelength distribution, spot size, pulse mode or treatment schedule;
whether peak irradiance would produce the same area exposure as the average value shown here.

Read Red Light Irradiance, Fluence and Dose Explained before trying to compare this output with a clinical paper or another panel.

Clinical evidence context

Where these wavelengths overlap with human research

Published device wavelengths: 660 / 850 nm (50/50).

This is a hardware-to-literature cross-reference, not a claim that this product treats any condition. A matching nominal wavelength does not reproduce a study's irradiance, dose, distance, treatment area, emitter geometry, schedule or patient population.

Research areas worth checking

Pattern hair loss — human studies commonly use visible-red wavelengths, especially around the mid-600 nm range.
Acne and inflammatory skin — red-light protocols exist, but acne studies may also use blue light and should not be generalized from panel specs.
Skin rejuvenation and photoaging — visible-red and red/NIR LED protocols have been studied with varied devices and endpoints.
Knee osteoarthritis — near-infrared wavelengths appear in the clinical literature, but wavelength alone does not establish an equivalent treatment protocol.
Muscle recovery and musculoskeletal pain — research spans red and near-infrared bands with substantial protocol variation.
Transcranial PBM and cognition — some research uses near-infrared wavelengths, but a body panel is not automatically equivalent to a head-targeted transcranial device.
See the full wavelength-by-condition evidence chart for evidence strength, treatment geometry and major caveats.

Do not infer from wavelength overlap

that this device is clinically proven for the linked condition;
that more wavelengths are better;
that the highest published irradiance is the best dose;
that an open wound should be treated with a consumer device without appropriate wound assessment.

For wounds specifically, start with the wound-care safety decision guide before interpreting any device specification.

Safety first

What should make you slow down?

Use the product as directed, avoid treating concentrated wellness products as automatically harmless, and ask a qualified clinician when your situation or medication use makes the decision less routine.

Where to buy

Current tracked merchants

Commerce note: merchant economics never enter our editorial score. Affiliate links are identified as (paid link) and use sponsored-link markup.

No merchant destination is currently tracked for this product.

Source trail

Primary documents and supporting evidence

Mito Red Original 2.0 Panel SeriesMito Red Light · Manufacturer · retrieved 2026-08-11
Independent ISO/IEC 17025 Panel Test DataMito Red Light / LightLab International · Independent lab · HTML data index · retrieved 2026-08-11
Product Manuals & VideosMito Red Light · Manufacturer manual · Manual index · retrieved 2026-08-11

Comparable products